Literature DB >> 25913616

Adenoma-like adenocarcinoma: a subtype of colorectal carcinoma with good prognosis, deceptive appearance on biopsy and frequent KRAS mutation.

Raul S Gonzalez1, Justin M M Cates2, Mary Kay Washington2, Robert Daniel Beauchamp3,4,5, Robert J Coffey4,6, Chanjuan Shi2.   

Abstract

AIMS: A subset of colorectal carcinomas (CRCs) architecturally and cytologically resembles adenomatous change, making them difficult to diagnose on biopsy. This subset has not been well characterized to date. METHODS AND
RESULTS: For 35 carcinomas with adenomatous-like areas (cytological and surface architectural appearance that would be insufficient to warrant a diagnosis of adenocarcinoma if evaluated on biopsy), we recorded staging information, molecular data, clinical outcome, whether precursor adenoma was present and whether previous biopsy had been diagnosed as malignant. Despite advanced T-category in 23 (66%) tumours, only seven (20%) had nodal metastases, and only five patients (15%) developed distant metastases. Fifteen cases (43%) had been diagnosed as adenoma on biopsy. Twenty-one resections (60%) showed no residual associated adenoma, including nine called adenoma on biopsy. Median follow-up was 44 months. Four patients (12%) died of disease; 22 were alive at last follow-up. KRAS mutation was seen in 14 of 24 (58%) and four of 17 (24%) were microsatellite-unstable. Patients had significantly improved survival compared to a cohort of patients with conventional well-differentiated CRC after controlling for age and stage (P = 0.011).
CONCLUSIONS: Adenoma-like adenocarcinoma is an uncommon variant of CRC with a low rate of metastasis and good prognosis. Biopsy diagnosis of this lesion may be challenging.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  adenoma-like adenocarcinoma; colorectal adenocarcinoma; gene mutation; microsatellite instability; prognosis

Mesh:

Substances:

Year:  2015        PMID: 25913616      PMCID: PMC4619179          DOI: 10.1111/his.12725

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  17 in total

1.  Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch?

Authors:  Kimmie Ng; Deborah Schrag
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

2.  Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.

Authors:  H J Andreyev; A R Norman; D Cunningham; J R Oates; P A Clarke
Journal:  J Natl Cancer Inst       Date:  1998-05-06       Impact factor: 13.506

3.  A Wilcoxon-type test for trend.

Authors:  J Cuzick
Journal:  Stat Med       Date:  1985 Jan-Mar       Impact factor: 2.373

4.  BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis.

Authors:  Chen Mao; Ru-Yan Liao; Li-Xin Qiu; Xi-Wen Wang; Hong Ding; Qing Chen
Journal:  Mol Biol Rep       Date:  2010-09-21       Impact factor: 2.316

5.  Villous tumor of the colon and rectum with special reference to roles of p53 and bcl-2 in adenoma-carcinoma sequence.

Authors:  T Yao; M Kajiwara; T Kouzuki; A Iwashita; M Tsuneyoshi
Journal:  Pathol Int       Date:  1999-05       Impact factor: 2.534

6.  Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease.

Authors:  Gabriel S Levi; Noam Harpaz
Journal:  Am J Surg Pathol       Date:  2006-08       Impact factor: 6.394

7.  Villous adenocarcinoma of the colon and rectum: a clinicopathologic study of 36 cases.

Authors:  Timothy S Loy; Paul A Kaplan
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

8.  Histologic phenotypes of colonic carcinoma in Sweden and in Japan.

Authors:  C A Rubio; A Yanagisawa; Y Kato
Journal:  Anticancer Res       Date:  1998 Jul-Aug       Impact factor: 2.480

9.  Pseudo-carcinomatous invasion in adenomatous polyps of the colon and rectum.

Authors:  T Muto; H J Bussey; B C Morson
Journal:  J Clin Pathol       Date:  1973-01       Impact factor: 3.411

10.  KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers.

Authors:  A I Phipps; D D Buchanan; K W Makar; A K Win; J A Baron; N M Lindor; J D Potter; P A Newcomb
Journal:  Br J Cancer       Date:  2013-03-19       Impact factor: 7.640

View more
  6 in total

1.  Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.

Authors:  Anna Melissa Schlitter; Kee-Taek Jang; Günter Klöppel; Burcu Saka; Seung-Mo Hong; Hyejeong Choi; George Johan Offerhaus; Ralph H Hruban; Yoh Zen; Björn Konukiewitz; Ivonne Regel; Michael Allgäuer; Serdar Balci; Olca Basturk; Michelle D Reid; Irene Esposito; Volkan Adsay
Journal:  Mod Pathol       Date:  2015-06-26       Impact factor: 7.842

2.  Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial-mesenchymal transition.

Authors:  Raul S Gonzalez; Won Jae Huh; Justin M M Cates; Kay Washington; R Daniel Beauchamp; Robert J Coffey; Chanjuan Shi
Journal:  Histopathology       Date:  2016-10-28       Impact factor: 5.087

3.  Associations among histological characteristics and patient outcomes in colorectal carcinoma with a mucinous component.

Authors:  Raul S Gonzalez; Justin M M Cates; Kay Washington
Journal:  Histopathology       Date:  2018-11-11       Impact factor: 5.087

Review 4.  The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers.

Authors:  Corina-Elena Minciuna; Mihai Tanase; Teodora Ecaterina Manuc; Stefan Tudor; Vlad Herlea; Mihnea P Dragomir; George A Calin; Catalin Vasilescu
Journal:  Comput Struct Biotechnol J       Date:  2022-09-12       Impact factor: 6.155

5.  Colorectal cancers with a residual adenoma component: Clinicopathologic features and KRAS mutation.

Authors:  Hyoun Wook Lee; Boram Song; Kyungneun Kim
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

6.  Adenoma-like adenocarcinoma: clinicopathologic characterization of a newly recognized subtype of colorectal carcinoma.

Authors:  Iván A González; Philip S Bauer; Jingxia Liu; Deyali Chatterjee
Journal:  Hum Pathol       Date:  2020-09-28       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.